<DOC>
	<DOCNO>NCT02570633</DOCNO>
	<brief_summary>The main objective study evaluate ginger efficacy prophylactic treatment migraine .</brief_summary>
	<brief_title>Ginger Capsules Prophylactic Treatment Migraine</brief_title>
	<detailed_description>Patients diagnosis migraine accord IHS criterion receive capsule 200 mg ginger extract ( 5 % active ingredient ) placebo ( cellulose ) take three time day 12 week .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Aged 18 60 year old ; Migraine diagnosis ; Agree sign inform consent . Patients headache characterized migraine ; Pregnant lactate woman ; Fertile sexually active woman use contraception ; Abuse painkiller , alcohol drug ; People hypersensitivity ginger compound ; People severe neurological disease ( e.g . epilepsy ) People use anticoagulant drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Ginger</keyword>
	<keyword>Prophylactic treatment</keyword>
</DOC>